A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT02705469 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-Resistant Prostate Cancer

Interventions

DRUG: ZEN003694

Sponsor

Zenith Epigenetics